No Detail Found!

Clinical Study of Hydromorphone Combined with Dexmedetomidine via Patient Controlled Analgesia for the Treatment of Acute Herpes Zoster Neuralgia

Author(s)
Qingwen Yu Department of Pain, Leshan Hospital of Traditional Chinese Medicine,Leshan,China
Jianxiong Wu Department of Pain, Leshan Hospital of Traditional Chinese Medicine,Leshan,China
Shuangchun Peng Department of Pain, Leshan Hospital of Traditional Chinese Medicine,Leshan,China
Changyan Huang Department of Pain, Leshan Hospital of Traditional Chinese Medicine,Leshan,China
Abstract
To investigate the e cacy of hydromorphone combined with dexmedetomidine with patient-controlled intravenous analgesia (PCIA) in treating patients with acute herpes zoster (HZ) neuralgia. Study Design: Randomised controlled trial. Place and Duration of the Study: Department of Pain, Leshan Hospital of Traditional Chinese Medicine, Leshan, China, from May 2023 to April 2024. Methodology: The patients diagnosed with acute HZ were randomly divided into two groups: The hydromorphone combined dexmedetomidine PCIA treatment group (Group H) and the oral tramadol control group (Group C). Both groups were given oral pregabalin and vitamin B1. Repeated measures analysis of variance, Chi-square test or Fisher's exact probability test, was used to compare the pain numeric rating scales (NRS) and the Pittsburgh sleep quality index (PSQI) of the two groups before and after 1, 4, and 12 weeks treatment (T0, T3, T4, and T5). The number of people experiencing HZ-related pain was at T4 and T5, with the levels of cluster of di erentiation 4 (CD4+), 8 (CD8+), and CD4+ / CD8+ before treatment, 24 hours, and 48 hours after treatment (T0, T1, T2), respectively. And the related adverse e ects were also monitored. Results: NRS and PSQI decreased signi cantly in both groups after treatment. Compared to Group C, Group H showed a signi cant decrease in NRS scores at T3 and T4 (p 0.05) in other adverse reactions, such as dizziness, nausea, and vomiting. Conclusion: Hydromorphone combined with dexmedetomidine PCIA is e ective in relieving HZ-related pain, and reducing the occurrence of postherpetic neuralgia (PHN). It shows a good therapeutic e ect, a high safety pro le, and an easy clinical application.
Publication Details
Page(s) 958-963
Published Journal: Journal of the College of Physicians and Surgeons Pakistan, Volume: 35, Issue: 08, Year: 2025

Request the full text from PASTIC

Keywords
Dexmedetomidine, patient-controlled analgesia, hydromorphone, Acute herpes zoster neuralgia, Oral tramadol
References
Huang Y,Xu C,Zeng T,Li Z,Xia Y,Tao G .2021 .Intravenous patient-controlled analgesia hydromorphone combined with pregabalin for the treatment of postherpetic neuralgia: A multicenter, randomised controlled study. Korean J Pain, 34(2) : 210-6.
AlMuammar S,Albogmi A,Alzahrani M,Alsharef F,Aljohani R,Aljilani T. .2023 .Herpes zoster vaccine awareness and acceptance among adults in Saudi Arabia: A survey-based cross-sectional study. Trop Dis Travel Med Vaccines, 10(1) : 17.
Zhang H,Zhang LR,Chu LC,Sun X,Jiang XW .2023 .Factors in uencing herpes zoster vaccination among older people in China: Results from a discrete choice experiment. Public Health, 04 : 33-4.
Wang L,Lan X,Lan Z,Xu S,He R,Z. R .2024 .The relationship between pain duration characteristics and pain intensity in herpes zoster-related pain: A single-center retrospective study. Front Med, 1466214 : 1466214.
Makharita MY,Amr YM MY .2020 .E ect of repeated paravertebral injections with local anesthetics and steroids on prevention of post-herpetic neuralgia. Pain Physician, 23(6) : 565-72.
Shen Y,Zhou X,Ji N,Luo F. .2023 .Clinical e cacy of tender point in ltration (TPI) for management of acute and subacute zoster-associated pain: A retrospective analysisP. ain Physician, 26(2) : E63-72.
Harden RN,Kaye AD,Kintanar T,Argo CE .2013 .Evidence-based guidance for the management of postherpetic neuralgia in primary care. Postgrad Med, 07(4) : 191-202.
Sarhill N,Walsh D,Nelson KA .2001 .Hydromorphone: Pharmacology and clinical applications in cancer patients. Support Care Cancer, 10(2) : 84-96.
Yang F,Liao P,You Y,Liang Y,Hu Y. .2021 .The e ectiveness of repetitive paravertebral block with ropivacaine and dexmedetomidine for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Postepy Dermatol Alergol, 106021(1) : 116-20.
Swarm RA,Paice JA,Anghelescu DL,Are M,Bruce JY,Buga S .2019 .NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 0038(8) : 977-1007.
Raskind MA,Peskind ER,Chow B,Harris C,Davis-Karim A,Holmes HA .2018 .Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med, 10(6) : 507-17.
Cohen JI. .2013 .Clinical practice: Herpes zoster. N Engl J Med, 10(3) : 255-63.
Werner RN,Nikkels AF,Marinovic B,Schafer M,CzarneckaOperacz M,Agius AM .2017 .European consensus-based (S2k) guideline on the management of herpes zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol, 10(1) : 20-9.
Dauri M,Lazzari M,Casali M,Tufaro G,Sabato E,Sabato AF .2014 .Long-term e cacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain. Clin Drug Investig, 10(5) : 309-16.
Di Cesare Mannelli L,Micheli L,Crocetti L,Giovannoni MP,Vergelli C .2017 .±2 adrenoceptor: A target for neuropathic pain treatment. Mini Rev Med Chem, 10(2) : 95-107.
Park HJ,Kim YH,Koh HJ,Park CS,Kang SH,Choi JH .2012 .Analgesic e ects of dexmedetomidine in vincristine-evoked painful neuropathic rats. J Korean Med Sci, 27(11) : 1411-7.
Lee HG,Choi JI,Kim YO,Yoon MH .2013 .The role of alpha-2 adrenoceptor subtype in the antiallodynic e ect of intraplantar dexmedetomidine in a rat spinal nerve ligation model. Neurosci Lett, 10 : 118-22.
Makharita MY .2017 .Prevention of post-herpetic neuralgia from dream to reality: A ten-step model. Pain Physician, 20(2) : E209-20.
Kaygusuz K,Kol IO,Duger C,Gursoy S,Ozturk H,Kayacan U .2012 .E ects of adding dexmedetomidine to levobupivacaine in axillary brachial plexus block. Curr Ther Res Clin Exp, 03(3) : 103-11.
Wang K,Wu M,Xu J,Wu C,Zhang B,Wang Ge .2019 .E ects of dexmedetomidine on perioperative stress, in ammation, and immune function: systematic review and meta-analysis. Br J Anaesth, 07(6) : 777-94.
Yang XH,Bai Q,Lv MM,Fu HG,Dong TL,Zhou Z TL .2017 .E ect of dexmedetomidine on immune function of patients undergoing radical mastectomy: A double blind and placebo control study. Eur Rev Med Pharmacol Sci, 21(5) : 1112-6.
0

Citations

0

Downloads

45

Views